Skip to main content

View full-text article in PMC

. 2023 Jul 13;27(2):287–294. doi: 10.4103/jomfp.jomfp_5_23

Table 2.

Assessment of Survivin and p53 immunoexpression in study groups

Immunomarker Parameters		Survivin			p53
Immunomarker Parameters		Group I (OPMD) Frequency (%) (n =30)	Group II OSCC) Frequency (%) (n =30)	P	Group I (OPMD) Frequency (%) (n =30)	Group II (OSCC) Frequency (%) (n =30)	P
Expression	Absent	1 (3.3%)	4 (13.3%)	0.161	4 (13.3%)	5 (16.7%)	0.718
	Present	29 (96.7%)	26 (86.7%)		26 (86.7%)	25 (83.3%)
Intensity	Weak (+)	2 (6.7%)	9 (30%)	0.035 (S)	15 (50%)	9 (30%)	0.293
	Moderate (++)	9 (30%)	5 (16.7%)		5 (16.7%)	4 (13.3%)
	Strong (+++)	18 (60%)	12 (40%)		6 (20%)	12 (40%)

S: Significant